摘要
目的 :探讨子宫内膜癌 (endometrialcarcinoma ,EMC)增殖活性以及雌、孕激素受体的表达与临床病理特性、预后的关系。方法 :采用免疫组织化学方法检测 74例子宫内膜癌增殖细胞核抗原 (proliferatingcellnucleusantigen ,PCNA)、雌激素受体 (estrogenreceptor ,ER)、孕激素受体 (progesteronereceptor ,PR)含量。结果 :PCNA在对照组和EMC中的阳性率分别为 30 .0 %和 82 .4% ,差异有显著性 (P <0 .0 1) ;在不同分化程度的EMC中PCNA阳性表达率差异无显著性 ,但PCNA阳性指数 (PI)评分 ,WD明显低于MD ,LD ,差异有显著性 (P <0 .0 0 1) ,且与EMC分化程度呈负相关(r = 0 .5 2 ,P <0 .0 1) ;PCNAPI评分与EMC临床期别之间呈正相关 (r =0 .5 5 ,P <0 .0 1)。EMC中ER ,PR阳性例数分别为 49例 (6 6 .2 % )和 5 6例 (75 .7% ) ,PCNA表达与ER ,PR受体之间呈负相关 ,r值分别为 - 0 .42 (P <0 .0 5 )和 - 0 .5 1(P <0 .0 5 )。结论 :ER和PR阳性、PCNAPI评分较低的子宫内膜癌 ,肿瘤细胞异型性小 ;反之 ,表现为侵犯邻近组织、扩散、转移等恶性生物学行为。ER ,PR和PCNA表达之间有明显互补性。PCNA表达结合ER ,PR检测具有方法简单、组织无需特殊处理等特点 ,适于对常规病理切片作回顾性研究 ,对鉴别肿瘤性质、预测预后均有?
Objective To investigate the proliferating ability of tumor cells in 74 cases with endometrial carcinoma (EMC), as well as define the correlation between clinical pathology, prognostic features and estrogen receptor (ER), progesterone receptor (PR). Methods Proliferating cell nucleus antigen (PCNA) and ER/PR content were examined using immunohistochemical assay. Results PCNA was expressed in both benign hyperplasia and EMC, but positive rate in the latter was significantly higher than that in the former (82.4% vs 30.0%)(P<0.01). EMC well differentiated had lower proliferating index (PI) score than those moderately and poorly differentiated(P<0.001), and the PI score was negatively related to the grade of differentiation(r= 0.52, P<0.01). PI score in early cases (Ⅰ/Ⅱ) was significantly lower than that in advanced ones(Ⅲ/Ⅳ) (P<0.05), and the PI score was positively related to the clinical stages (r=0.55, P<0.01). Positive rates of ER, PR were 66.2% (49/74) and 75.7%(56/74) respectively, expression of PCNA was negatively related with ER and PR(r-0.42, 0.51,respectively,P<0.05). Conclusions EMC cells with poorer differentiation or in more advanced stages have faster proliferating ability and aggressive biological behavior. Expression of PCNA combined with detection of ER/PR not only apts to retrospective study, but also has some prognostic value.
出处
《湖南医科大学学报》
CSCD
北大核心
2001年第2期123-125,共3页
Bulletin of Hunan Medical University
关键词
子宫内膜肿瘤
增殖细胞核抗原
雌激素受体
孕激素受体
免疫组织化学
endometrial neoplasms
proliferating cell nucleus antigen *
receptor, estrogen
receptor, progesterone
immunohistochemistry